tiprankstipranks
Gilead Sciences (MX:GILD)
:GILD
Mexico Market
GILD
Gilead Sciences
RESEARCH TOOLSreports

Gilead Sciences (GILD) Stock News & Sentiment

0 Followers
Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
Premium
Company Announcements
Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
12d ago
GILD
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
Premium
Market News
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
18d ago
GILD
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
Premium
Market News
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
27d ago
MRK
TEM
Gilead Sciences Earnings Call Highlights Strong Core Growth
Premium
Company Announcements
Gilead Sciences Earnings Call Highlights Strong Core Growth
1M ago
GILD
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
Premium
Ratings
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
1M ago
GILD
Gilead: Buy Rating Reaffirmed on Strong Fundamentals and HIV Franchise Momentum; $165 Price Target Maintained
Premium
Ratings
Gilead: Buy Rating Reaffirmed on Strong Fundamentals and HIV Franchise Momentum; $165 Price Target Maintained
1M ago
GILD
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
Premium
Ratings
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
1M ago
GILD
More MX:GILD News >

GILD News on the Web

Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales
Insider Monkey
Neutral
RBC Capital Keeps Their Hold Rating on Gilead Sciences (GILD)
TipRanks News
Neutral
Gilead Sciences, Inc. at Cantor Global Healthcare Conference Transcript
GuruFocus News
Neutral
Cramer's lightning round: 'I am not going to put my money on AstraZeneca'
CNBC
Neutral
Lilly perseveres in a bad day for drug stocks — plus, Boeing's mixed deliveries
CNBC
Neutral
Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market?
Insider Monkey
Neutral
Gilead Sciences (GILD) Receives a Buy from Bernstein
TipRanks News
Neutral
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
The Motley Fool
Bullish

News Score - Last 7 Days

Neutral
MX:GILD
Sector Average
Media Buzz
This Week13 articles
Weekly Average13.25 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:GILD’s Media Buzz Sentiment?
13 articles about MX:GILD were published this week. In an average week, 13.25 articles are published.
    What is MX:GILD’s weekly average amount of articles?
    In an average week, 13.25 articles about MX:GILD are published.
      What is MX:GILD’s News Sentiment?
      100% of articles about MX:GILD were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week